Walleye Trading »

Crinetics Pharmaceuticals In shares owned by Walleye Trading

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Walleye Trading from 13F filings

Historical chart of Walleye Trading investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Walleye Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Walleye Trading

Quarter filed Position value Share count Share price at filing
2023-12-31 $711k 20k 35.58
2023-09-30 $2.1M 72k 29.74
2023-06-30 $362k 20k 18.02
2023-03-31 $404k 25k 16.06
2022-12-31 $326k 18k 18.30
2022-09-30 $445k 23k 19.63

More positions owned by Walleye Trading

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A (META)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Intel Corporation Call Option (INTC)
Pdd Holdings Sponsored Ads Call Option (PDD)
Palo Alto Networks Put Option (PANW)
Alibaba Group Hldg Sponsored Ads (BABA)
Crowdstrike Hldgs Cl A Put Option (CRWD)

View all positions for Walleye Trading

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In